SEC Form 4 · accession 0001290929-15-000002
AOXING PHARMACEUTICAL COMPANY, INC. · AXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Zhenjiang Yue
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Aug 28, 2014
Accepted (ET)
Feb 9, 2015 · 2:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 28, 2014 | A | 7,289,199 | $0.39 | A | 12,161,375 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 1,500,000 shares owned of record by spouse, as to which beneficial ownership is disclaimed.